John I Bell Selected Research

Human Influenza (Influenza)

7/2003

A structural basis for immunodominant human T cell receptor recognition.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

John I Bell Research Topics

Disease

10	Infections 01/2023 - 01/2007
5	Multiple Sclerosis 09/2013 - 08/2006
3	COVID-19 01/2022 - 01/2021
2	Reinfection 01/2023 - 10/2021
2	Melanoma (Melanoma, Malignant) 01/2023 - 09/2007
2	Neoplasms (Cancer) 01/2023 - 01/2006
1	Uveal melanoma 01/2023
1	Breakthrough Infections 01/2023
1	Autoimmune Diseases (Autoimmune Disease) 11/2016
1	Demyelinating Diseases (Demyelinating Disease) 09/2013
1	Necrosis 08/2012
1	Psoriasis (Pustulosis Palmaris et Plantaris) 08/2012
1	Rheumatoid Arthritis 08/2012
1	Disease Susceptibility (Diathesis) 11/2008
1	Virus Diseases (Viral Diseases) 02/2008
1	HIV Infections (HIV Infection) 01/2007
1	Encephalomyelitis (Myeloencephalitis) 08/2006
1	Hepatitis B 06/2006
1	Severe Acute Respiratory Syndrome 11/2004
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 02/2004
1	Narcolepsy 02/2004
1	Human Influenza (Influenza) 07/2003

Drug/Important Bio-Agent (IBA)

5	Immunoglobulin G (IgG)IBA 01/2023 - 01/2020
5	VaccinesIBA 01/2023 - 01/2021
5	BNT162 VaccineIBA 01/2022 - 01/2021
4	Peptides (Polypeptides)IBA 01/2023 - 02/2004
3	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2023 - 02/2008
3	Proteins (Proteins, Gene)FDA Link 01/2023 - 07/2003
2	AntigensIBA 01/2023 - 09/2007
2	COVID-19 VaccinesIBA 01/2022 - 01/2021
1	tebentafuspIBA 01/2023
1	2019-nCoV Vaccine mRNA-1273IBA 01/2022
1	EpitopesIBA 01/2022
1	AntibodiesIBA 10/2021
1	ChAdOx1 nCoV-19IBA 01/2021
1	Immunoglobulin M (IgM)IBA 01/2020
1	TYK2 Kinase (Tyrosine Kinase 2)IBA 11/2016
1	Tumor Necrosis Factor InhibitorsIBA 09/2013
1	Type I Tumor Necrosis Factor ReceptorsIBA 08/2012
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 08/2012
1	HLA-A Antigens (HLA-A)IBA 11/2008
1	HLA Antigens (Human Leukocyte Antigens)IBA 11/2008
1	HLA-A*02:01 antigenIBA 11/2008
1	MART-1 AntigenIBA 09/2007
1	AutoantigensIBA 09/2007
1	AIDS VaccinesIBA 01/2007
1	HLA-DR Antigens (HLA-DR)IBA 10/2006
1	HLA-DR2 Antigen (HLA DR2 Antigen)IBA 10/2006
1	Cytokine Receptors (Cytokine Receptor)IBA 06/2006
1	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2006
1	Histocompatibility Antigens Class IIIBA 02/2004

Therapy/Procedure

3	Therapeutics 01/2023 - 08/2006
1	Drug Therapy (Chemotherapy) 01/2023
1	Immunotherapy 01/2023